Início  /   Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers


Women with mutations in BRCA1 or BRCA2 are at high risk of developing breast cancer and, in British Columbia, Canada, are offered screening with both magnetic resonance imaging (MRI) and mammography to facilitate early detection. MRI is more sensitive than mammography but is more costly and produces more false positive results. The purpose of this study was to calculate the cost-effectiveness of MRI screening for breast cancer in BRCA1/2 mutation carriers in a Canadian setting.